• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘压力定量吸入器性能:递送系统中的推进剂效应研究

Asthma pressurised metered dose inhaler performance: propellant effect studies in delivery systems.

作者信息

Sellers William F S

机构信息

Broadgate House, 22 Broadgate, Great Easton, Leicestershire, LE16 8SH UK.

出版信息

Allergy Asthma Clin Immunol. 2017 Jun 29;13:30. doi: 10.1186/s13223-017-0202-0. eCollection 2017.

DOI:10.1186/s13223-017-0202-0
PMID:28670327
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5492461/
Abstract

BACKGROUND

Current pressurised metered dose asthma inhaler (pMDI) propellants are not inert pharmacologically as were previous chlorofluorocarbons, have smooth muscle relaxant' partial pressure effects in the lungs and inhaled hydrofluoroalkane 134a (norflurane) has anaesthetic effects. Volumes of propellant gas per actuation have never been measured.

METHODS

In-vitro studies measured gas volumes produced by pMDIs on air oxygen (O) levels in valved holding chambers (VHC) and the falls in O% following actuation into lung ventilator delivery devices.

RESULTS

Volumes of propellant gas hydrofluoroalkane (HFA) 134a and 227ea and redundant chlorofluorocarbons (CFC) varied from 7 ml per actuation from a small salbutamol HFA inhaler to 16 ml from the larger. Similar-sized CFC pMDI volumes were 15.6 and 20.4 ml. Each HFA salbutamol inhaler has 220 full volume discharges; total volume of gas from a small 134a pMDI was 1640 ml, and large 3885 ml. Sensing the presence of liquid propellant by shaking was felt at the 220th discharge in both large and small inhalers. Because of a partial pressure effect, VHC O% in air was reduced to 11% in the smallest 127 ml volume VHC following 10 actuations of a large 134a salbutamol inhaler. The four ventilator delivery devices studied lowered 100% oxygen levels to a range of 93 to 81% after five actuations, depending on the device and type of pMDI used.

CONCLUSION

Pressurised inhaler propellants require further study to assess smooth muscle relaxing properties.

摘要

背景

当前的压力定量吸入器(pMDI)推进剂在药理上并非像以前的氯氟烃那样呈惰性,在肺部具有平滑肌舒张的分压效应,且吸入的氢氟烷烃134a(诺氟烷)具有麻醉作用。每次按压喷出的推进剂气体体积从未被测量过。

方法

体外研究测量了pMDI在带阀储物罐(VHC)中对空气氧(O)水平产生的气体体积,以及在启动进入肺通气输送装置后O%的下降情况。

结果

氢氟烷烃(HFA)134a和227ea以及多余的氯氟烃(CFC)推进剂气体体积各不相同,从小型沙丁胺醇HFA吸入器每次按压喷出7毫升到大型的16毫升不等。类似尺寸的CFC pMDI体积分别为15.6毫升和20.4毫升。每个HFA沙丁胺醇吸入器有220次全量喷出;小型134a pMDI喷出的气体总体积为1640毫升,大型的为3885毫升。在大小吸入器中,第220次喷出时通过摇晃能感觉到液体推进剂的存在。由于分压效应,在一个大型134a沙丁胺醇吸入器按压10次后,最小127毫升体积的VHC中的空气O%降至11%。所研究的四种通气输送装置在按压五次后将100%的氧水平降至93%至81%的范围,这取决于所使用的装置和pMDI类型。

结论

压力定量吸入器推进剂需要进一步研究以评估其平滑肌舒张特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ff2/5492461/dd4696b50e57/13223_2017_202_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ff2/5492461/dd4696b50e57/13223_2017_202_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ff2/5492461/dd4696b50e57/13223_2017_202_Fig1_HTML.jpg

相似文献

1
Asthma pressurised metered dose inhaler performance: propellant effect studies in delivery systems.哮喘压力定量吸入器性能:递送系统中的推进剂效应研究
Allergy Asthma Clin Immunol. 2017 Jun 29;13:30. doi: 10.1186/s13223-017-0202-0. eCollection 2017.
2
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
3
Factors affecting the efficiency of aerosol therapy with pressurised metered-dose inhalers through plastic spacers.影响通过塑料储雾罐使用压力定量吸入器进行雾化治疗效率的因素。
Swiss Med Wkly. 2001 Jan 12;131(1-2):14-8. doi: 10.4414/smw.2001.05897.
4
The technical transition to CFC-free inhalers.向无氯氟烃吸入器的技术转型。
Br J Clin Pract Suppl. 1997 May;89:22-7.
5
Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.通过氢氟烷烃134a压力定量吸入器每日两次给予1毫克丙酸氟替卡松治疗重度哮喘患者的临床疗效和安全性。英国研究小组。
Respir Med. 2000 Jun;94 Suppl B:S42-50.
6
Pharmaceutical transition to non-CFC pressurized metered dose inhalers.制药行业向非氯氟烃(CFC)压力定量吸入器的转变。
Respir Med. 2000 Jun;94 Suppl B:S3-9.
7
From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs.来自氢氟烷烃压力定量吸入器(pMDIs)及其与氯氟烃pMDIs的可比性。
Respir Med. 2000 Jun;94 Suppl B:S10-6.
8
Plume temperature emitted from metered dose inhalers.定量吸入器喷出的羽流温度。
Int J Pharm. 2011 Feb 28;405(1-2):9-15. doi: 10.1016/j.ijpharm.2010.11.037. Epub 2010 Dec 1.
9
Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.用氢氟烷烃定量吸入器给药的异丙托溴铵/硫酸沙丁胺醇治疗慢性阻塞性肺疾病的疗效和安全性。
Int J Chron Obstruct Pulmon Dis. 2016 Jun 30;11:1469-76. doi: 10.2147/COPD.S89923. eCollection 2016.
10
Equivalence of salbutamol 200 microg four times daily propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. Eastern European study group.沙丁胺醇200微克每日四次,分别采用抛射剂11和12或氢氟烷烃134a推进给药,在轻至中度哮喘患者中的等效性。东欧研究组。
Respir Med. 2000 Jun;94 Suppl B:S22-8. doi: 10.1016/s0954-6111(00)90150-1.

引用本文的文献

1
Inhalable Nanomaterial Discoveries for Lung Cancer Therapy: A Review.用于肺癌治疗的可吸入纳米材料研究进展:综述
Pharmaceutics. 2025 Jul 31;17(8):996. doi: 10.3390/pharmaceutics17080996.
2
Environmental impact and sustainability of nanocellulose-based nitrated polymers in propellants.推进剂中基于纳米纤维素的硝化聚合物的环境影响与可持续性
RSC Adv. 2025 Jul 10;15(30):24167-24191. doi: 10.1039/d5ra02169c.
3
Intranasal and Pulmonary Lipid Nanoparticles for Gene Delivery: Turning Challenges into Opportunities.用于基因递送的鼻内和肺部脂质纳米颗粒:将挑战转化为机遇

本文引用的文献

1
Misuse of anaesthetic gases.
Anaesthesia. 2016 Oct;71(10):1140-3. doi: 10.1111/anae.13551. Epub 2016 Jul 9.
2
Preventing out-of-hospital asthma deaths.预防院外哮喘死亡。
Thorax. 2015 Aug;70(8):718. doi: 10.1136/thoraxjnl-2015-207207. Epub 2015 May 20.
3
Inhaled and intravenous treatment in acute severe and life-threatening asthma.吸入和静脉治疗急性严重和危及生命的哮喘。
Br J Anaesth. 2013 Feb;110(2):183-90. doi: 10.1093/bja/aes444. Epub 2012 Dec 12.
Int J Nanomedicine. 2025 Jun 23;20:8085-8099. doi: 10.2147/IJN.S517385. eCollection 2025.
4
Effective respiratory management of asthma and COPD and the environmental impacts of inhalers.哮喘和慢性阻塞性肺疾病的有效呼吸管理以及吸入器对环境的影响。
NPJ Prim Care Respir Med. 2023 Jul 1;33(1):24. doi: 10.1038/s41533-023-00346-7.
5
Oral enoximone allows the reduction and discontinuation of inhaled steroids and beta2 agonists in asthmatic children.口服依诺昔酮可减少并停用哮喘儿童的吸入性类固醇和β2激动剂。
Int J Pediatr Adolesc Med. 2022 Jun;9(2):147-151. doi: 10.1016/j.ijpam.2021.02.002. Epub 2021 Feb 19.
6
Chemoenzymatic synthesis of polypeptides in neat 1,1,1,2-tetrafluoroethane solvent.在纯1,1,1,2-四氟乙烷溶剂中进行多肽的化学酶法合成。
RSC Adv. 2018 Oct 22;8(63):35936-35945. doi: 10.1039/c8ra06657d.
7
Nitration of aromatics with dinitrogen pentoxide in a liquefied 1,1,1,2-tetrafluoroethane medium.在液化1,1,1,2 - 四氟乙烷介质中用五氧化二氮对芳烃进行硝化反应。
RSC Adv. 2021 Jul 27;11(42):25841-25847. doi: 10.1039/d1ra04536a.
8
Packaging and Delivery of Asthma Therapeutics.哮喘治疗药物的包装与递送
Pharmaceutics. 2021 Dec 31;14(1):92. doi: 10.3390/pharmaceutics14010092.
9
Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England.切换至低全球变暖潜势吸入器的成本。基于英格兰国民保健服务处方数据的经济和碳足迹分析。
BMJ Open. 2019 Oct 29;9(10):e028763. doi: 10.1136/bmjopen-2018-028763.
10
Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes.了解干粉吸入器:关键技术和患者偏好属性。
Adv Ther. 2019 Oct;36(10):2547-2557. doi: 10.1007/s12325-019-01066-6. Epub 2019 Sep 2.
4
What can we learn from asthma in elite athletes?
BMJ. 2012 Apr 24;344:e2556. doi: 10.1136/bmj.e2556.
5
Airway emergency during anaesthesia using a metered-dose inhaler--II.
Anaesthesia. 2011 Jun;66(6):531. doi: 10.1111/j.1365-2044.2011.06771_2.x.
6
The asthmatic athlete: inhaled Beta-2 agonists, sport performance, and doping.哮喘运动员:吸入β2 激动剂、运动表现和兴奋剂。
Clin J Sport Med. 2011 Jan;21(1):46-50. doi: 10.1097/IAE.0b013e318203c0ef.
7
Endemic asthma inhaler abuse among antisocial adolescents.反社会青少年中存在的地方性哮喘吸入器滥用现象。
Drug Alcohol Depend. 2008 Jul 1;96(1-2):22-9. doi: 10.1016/j.drugalcdep.2008.01.022. Epub 2008 Mar 14.
8
Medical aerosol propellant interference with infrared anaesthetic gas monitors.
Br J Anaesth. 2004 Jun;92(6):865-9. doi: 10.1093/bja/aeh154. Epub 2004 Apr 30.
9
Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers.氢氟烷烃-134a倍氯米松在肺部的沉积量大于氯氟烃氟替卡松和氯氟烃倍氯米松:一项针对健康志愿者的交叉研究。
Chest. 2002 Aug;122(2):510-6. doi: 10.1378/chest.122.2.510.
10
European Respiratory Society Guidelines on the use of nebulizers.欧洲呼吸学会雾化器使用指南。
Eur Respir J. 2001 Jul;18(1):228-42. doi: 10.1183/09031936.01.00220001.